[go: up one dir, main page]

UA42739C2 - Спосіб інгібування фоторозкладу фармацевтично активних сполук, таблетка та капсула, що їх містять - Google Patents

Спосіб інгібування фоторозкладу фармацевтично активних сполук, таблетка та капсула, що їх містять

Info

Publication number
UA42739C2
UA42739C2 UA96041574A UA96041574A UA42739C2 UA 42739 C2 UA42739 C2 UA 42739C2 UA 96041574 A UA96041574 A UA 96041574A UA 96041574 A UA96041574 A UA 96041574A UA 42739 C2 UA42739 C2 UA 42739C2
Authority
UA
Ukraine
Prior art keywords
inhibition
dye
pharmaceutical active
photodisintegration
capsule
Prior art date
Application number
UA96041574A
Other languages
English (en)
Russian (ru)
Inventor
Віллард мол. Ньюлін
Виллард мл. Ньюлин
Шарон М. Лафлін
Шарон М. ЛАФЛИН
Original Assignee
Пфайзер Інк.
Пфайзер Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Інк., Пфайзер Инк. filed Critical Пфайзер Інк.
Publication of UA42739C2 publication Critical patent/UA42739C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polymerisation Methods In General (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Спосіб інгібування фоторозпаду фармацевтично активної сполуки передбачає використання сполуки формули: та її енольної форми чи її фармацевтично прийнятної основної солі, де Х - Н, CI чи F; Y - Н чи CI; R - бензил чи тієніл, кожний необов’язково заміщений CI чи F. У якості засобу, що поглинає світло, використовують барвник, що вибрано з групи, що складається з жовтого барвника N 6, червоного барвника N 40, червоного барвника N 3, жовтого пігменту N 6, червоного пігменту N 40 та червоного пігменту N 3 чи пакувальний матеріал, що ефективний у поглинанні світла.
UA96041574A 1995-04-24 1995-04-24 Спосіб інгібування фоторозкладу фармацевтично активних сполук, таблетка та капсула, що їх містять UA42739C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Publications (1)

Publication Number Publication Date
UA42739C2 true UA42739C2 (uk) 2001-11-15

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
UA96041574A UA42739C2 (uk) 1995-04-24 1995-04-24 Спосіб інгібування фоторозкладу фармацевтично активних сполук, таблетка та капсула, що їх містять

Country Status (30)

Country Link
EP (1) EP0827399A1 (uk)
JP (1) JPH10506635A (uk)
KR (1) KR100189585B1 (uk)
CN (1) CN1053667C (uk)
AP (1) AP607A (uk)
AR (1) AR002728A1 (uk)
AU (1) AU692378B2 (uk)
BG (1) BG100531A (uk)
BR (1) BR9602024A (uk)
CO (1) CO4700418A1 (uk)
FI (1) FI973988A0 (uk)
HR (1) HRP960194A2 (uk)
HU (1) HU216544B (uk)
IL (1) IL117969A0 (uk)
IS (1) IS4339A (uk)
MA (1) MA23848A1 (uk)
NO (1) NO961622L (uk)
NZ (1) NZ286432A (uk)
OA (1) OA10286A (uk)
PE (1) PE34397A1 (uk)
RO (1) RO113305B1 (uk)
RU (1) RU2109510C1 (uk)
SG (1) SG64924A1 (uk)
SI (1) SI9600133A (uk)
SK (1) SK51296A3 (uk)
TR (1) TR199600300A2 (uk)
UA (1) UA42739C2 (uk)
WO (1) WO1996033701A1 (uk)
YU (1) YU25096A (uk)
ZA (1) ZA963210B (uk)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019132959A1 (en) 2017-12-29 2019-07-04 Kraft Foods Group Brands Llc Improved oxidative stability of oil-in-water emulsions using natural stabilizers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
NZ286432A (en) 1998-05-27
SK51296A3 (en) 1997-04-09
CN1053667C (zh) 2000-06-21
HUP9601057A2 (en) 1997-04-28
AP607A (en) 1997-08-27
IL117969A0 (en) 1996-08-04
KR960037656A (ko) 1996-11-19
AU692378B2 (en) 1998-06-04
JPH10506635A (ja) 1998-06-30
FI973988A (fi) 1997-10-17
CN1139110A (zh) 1997-01-01
FI973988A0 (fi) 1997-10-17
SG64924A1 (en) 1999-05-25
AP9600787A0 (en) 1996-04-30
HU216544B (hu) 1999-07-28
NO961622D0 (no) 1996-04-23
HU9601057D0 (en) 1996-06-28
WO1996033701A1 (en) 1996-10-31
IS4339A (is) 1996-10-25
NO961622L (no) 1996-10-25
SI9600133A (en) 1996-10-31
AU5085196A (en) 1996-11-07
TR199600300A2 (tr) 1996-11-21
KR100189585B1 (ko) 1999-06-01
AR002728A1 (es) 1998-04-29
BR9602024A (pt) 1998-10-06
PE34397A1 (es) 1997-09-29
CO4700418A1 (es) 1998-12-29
YU25096A (sh) 1998-08-14
BG100531A (en) 1997-06-30
EP0827399A1 (en) 1998-03-11
RU2109510C1 (ru) 1998-04-27
ZA963210B (en) 1997-10-23
HRP960194A2 (en) 1998-02-28
MA23848A1 (fr) 1996-12-31
RO113305B1 (ro) 1998-06-30
HUP9601057A3 (en) 1997-05-28
OA10286A (en) 1997-09-19

Similar Documents

Publication Publication Date Title
HUP9601033A3 (en) Benzofurane derivatives, process for their preparation, use of them as intermediate and pharmaceutical compositions containing the compounds
HUP9701694A3 (en) Indolinone derivatives for the treatment of disease, use thereof, pharmaceutical compositions containing these compounds
FI942076A0 (fi) Sappihappojohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkaaineina
AR027162A1 (es) Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen
NO973923D0 (no) Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
NO944700D0 (no) Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene
FI943421A (fi) 1,5-bentsodiatsepiinijohdannaiset ja niiden käyttö lääkkeenä
MX9202619A (es) Derivados de oxa tiolano cristalino, metodo para su preparacion y formulacion farmaceutica que los contiene.
NO920451D0 (no) Fremgangsmaate ved fremstilling av alkalimetallklorat m.m.
FI925633A0 (fi) Foerfarande foer framstaellning av en farmaceutisk sammansaettning som selektivt saenker lipidnivaon i blodet
CA2015473A1 (en) Triphenylmethane derivatives
NO980059L (no) Nye oksazolidinonderivater, fremgangsmåte for fremstilling av dem, samt medikamenter som inneholder disse forbindelsene
DE69029231D1 (de) Indolderivate, ihre herstellung und diese enthaltendes arzneimittel zum verhindern und behandeln von nephritis
DE69600601D1 (de) Heterocyclische, aromatische Verbindungen, pharmazeutische und kosmetische Zusammensetzungen,die sie enthalten, und Verwendungen.
ATE13298T1 (de) Azepinderivate, ihre herstellung und diese enthaltende arzneimittel.
NO911577D0 (no) Fremgangsmaate til fremstilling av astaxanthin i phaffia rhodozyma.
DE68901859D1 (de) 2-benzothiazolamin-derivate enthaltende arzneimittel, verbindungen und ihre herstellung.
NO974563D0 (no) Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
UA42739C2 (uk) Спосіб інгібування фоторозкладу фармацевтично активних сполук, таблетка та капсула, що їх містять
NO903347L (no) 14,17alfa-ethano- og ethanooestratriener, fremgangsmaate forfremstilling av disse forbindelser, saavel som anvendelse av dem for fremstilling av legemidler.
FI973644A (fi) Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi
IL89335A (en) 6-oxo-pyridazine derivatives, a process for their preparation and pharmaceutical compositions containing these compounds
FI834061A (fi) 2-piperazinylkinazolinderivat, framstaellning av dem och farmaceutiska kompositioner innehaollande dem
NO911845D0 (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive trisykliske forbindelser.
NO153951C (no) Fremgangsmaate for fremstilling av en farmasoeytisk tilberedning som inneholder 8-metoksy-furo-(3[ ,2[:6,7)-cumarin.